SYN-TECH Chemical & Pharmaceutical Co. Ltd.(TW:1777)
NT$74.800.00 (0.00%)
TW:1777
SYN-TECH Chemical & Pharmaceutical Co. Ltd. financials statements
NT$74.80
At close:0.00 (0.00%)
SYN-TECH Chemical & Pharmaceutical Co. Ltd. (1777) Ratios
SYN-TECH Chemical & Pharmaceutical Co. Ltd. Ratios
TW:1777's free cash flow for Q2 2026 was NT$-1.14M. For the 2026 fiscal year, TW:1777's free cash flow was decreased by NT$-13.21M and operating cash flow was NT$12.07M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.03 | 6.08 | 2.80 | 3.17 | 2.54 |
| Quick Ratio | 3.91 | 3.78 | 1.89 | 2.46 | 2.16 |
| Cash Ratio | 3.44 | 2.99 | 1.32 | 1.68 | 1.46 |
| Solvency Ratio | 1.11 | 1.84 | 0.62 | 0.65 | 0.27 |
| Operating Cash Flow Ratio | 1.84 | 2.84 | 0.52 | 0.85 | 0.18 |
| Short-Term Operating Cash Flow Coverage | 3.21 | 12.28 | 0.77 | 1.19 | 0.21 |
| Net Current Asset Value | NT$ 1.16B | NT$ 1.04B | NT$ 836.75M | NT$ 1.01B | NT$ 1.22B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.04 | 0.14 | 0.15 | 0.26 |
| Debt-to-Equity Ratio | 0.09 | 0.04 | 0.17 | 0.19 | 0.39 |
| Debt-to-Capital Ratio | 0.08 | 0.04 | 0.15 | 0.16 | 0.28 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.14 | 1.11 | 1.25 | 1.26 | 1.46 |
| Debt Service Coverage Ratio | 2.25 | 10.21 | 1.07 | 0.71 | 0.30 |
| Interest Coverage Ratio | 318.90 | 163.93 | 49.12 | 40.24 | 49.72 |
| Debt to Market Cap | 0.05 | 0.01 | 0.09 | 0.10 | 0.31 |
| Interest Debt Per Share | 5.12 | 2.54 | 9.16 | 9.73 | 21.80 |
| Net Debt to EBITDA | -1.76 | -0.86 | -0.61 | -1.31 | -1.94 |
| Profitability Margins | |||||
| Gross Profit Margin | 34.16% | 38.72% | 36.74% | 36.60% | 31.80% |
| EBIT Margin | 24.60% | 38.99% | 28.66% | 24.15% | 18.87% |
| EBITDA Margin | 35.92% | 50.44% | 38.63% | 32.35% | 26.87% |
| Operating Profit Margin | 24.60% | 27.91% | 25.29% | 24.15% | 18.87% |
| Pretax Profit Margin | 25.68% | 38.82% | 28.15% | 37.19% | 22.50% |
| Net Profit Margin | 20.12% | 31.27% | 22.52% | 29.94% | 19.83% |
| Continuous Operations Profit Margin | 20.12% | 31.27% | 22.52% | 29.94% | 19.83% |
| Net Income Per EBT | 78.34% | 80.55% | 80.00% | 80.50% | 88.16% |
| EBT Per EBIT | 104.40% | 139.11% | 111.32% | 153.98% | 119.20% |
| Return on Assets (ROA) | 8.84% | 13.79% | 8.65% | 10.62% | 6.12% |
| Return on Equity (ROE) | 10.10% | 15.36% | 10.83% | 13.43% | 8.93% |
| Return on Capital Employed (ROCE) | 12.05% | 13.33% | 11.77% | 10.47% | 8.20% |
| Return on Invested Capital (ROIC) | 8.85% | 10.53% | 8.24% | 7.55% | 5.39% |
| Return on Tangible Assets | 8.84% | 13.79% | 8.65% | 10.62% | 6.12% |
| Earnings Yield | 7.95% | 9.36% | 6.61% | 7.86% | 7.70% |
| Efficiency Ratios | |||||
| Receivables Turnover | 10.39 | 7.93 | 3.94 | 3.71 | 9.73 |
| Payables Turnover | 1096.20 | 341.48 | 82.33 | 252.35 | 172.00 |
| Inventory Turnover | 2.51 | 1.53 | 1.53 | 1.77 | 1.89 |
| Fixed Asset Turnover | 0.93 | 0.84 | 0.77 | 0.85 | 1.23 |
| Asset Turnover | 0.44 | 0.44 | 0.38 | 0.35 | 0.31 |
| Working Capital Turnover Ratio | 1.11 | 1.24 | 1.11 | 0.83 | 0.96 |
| Cash Conversion Cycle | 179.95 | 283.32 | 326.27 | 303.38 | 228.37 |
| Days of Sales Outstanding | 35.13 | 46.03 | 92.61 | 98.41 | 37.50 |
| Days of Inventory Outstanding | 145.15 | 238.36 | 238.09 | 206.41 | 192.99 |
| Days of Payables Outstanding | 0.33 | 1.07 | 4.43 | 1.45 | 2.12 |
| Operating Cycle | 180.28 | 284.39 | 330.70 | 304.82 | 230.49 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 12.55 | 13.96 | 5.88 | 9.61 | 4.31 |
| Free Cash Flow Per Share | 11.24 | 9.17 | -3.93 | -1.09 | 0.84 |
| Dividend Paid and CapEx Coverage Ratio | 1.90 | 1.68 | 0.46 | 0.76 | 0.61 |
| Capital Expenditure Coverage Ratio | 9.60 | 2.91 | 0.60 | 0.90 | 1.19 |
| Operating Cash Flow Coverage Ratio | 2.46 | 5.59 | 0.65 | 1.00 | 0.20 |
| Operating Cash Flow to Sales Ratio | 0.43 | 0.50 | 0.24 | 0.43 | 0.17 |
| Free Cash Flow Yield | 15.23% | 9.73% | -4.61% | -1.30% | 1.29% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.57 | 10.69 | 15.13 | 12.72 | 12.98 |
| Price-to-Sales (P/S) Ratio | 2.53 | 3.34 | 3.41 | 3.81 | 2.58 |
| Price-to-Book (P/B) Ratio | 1.27 | 1.64 | 1.64 | 1.71 | 1.16 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 6.57 | 10.27 | -21.70 | -77.15 | 77.35 |
| Price-to-Operating Cash Flow Ratio | 5.88 | 6.75 | 14.48 | 8.76 | 15.16 |
| Price-to-Earnings Growth (PEG) Ratio | -0.38 | 0.19 | -1.01 | 0.40 | -0.80 |
| Enterprise Value Multiple | 5.29 | 5.76 | 8.21 | 10.46 | 7.65 |
| Enterprise Value | 2.47B | 3.66B | 3.53B | 3.34B | 1.84B |
| EV to EBITDA | 5.29 | 5.76 | 8.21 | 10.46 | 7.65 |
| EV to Sales | 1.90 | 2.91 | 3.17 | 3.38 | 2.06 |
| EV to Free Cash Flow | 4.93 | 8.94 | -20.19 | -68.58 | 61.73 |
| EV to Operating Cash Flow | 4.41 | 5.87 | 13.48 | 7.79 | 12.10 |
| Tangible Book Value Per Share | 58.09 | 57.41 | 51.98 | 49.32 | 56.26 |
| Shareholders’ Equity Per Share | 58.09 | 57.41 | 51.98 | 49.32 | 56.27 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.19 | 0.20 | 0.16 | 0.11 |
| Revenue Per Share | 29.16 | 28.20 | 25.00 | 22.12 | 25.34 |
| Net Income Per Share | 5.87 | 8.82 | 5.63 | 6.62 | 5.03 |
| Tax Burden | 0.78 | 0.81 | 0.80 | 0.80 | 0.88 |
| Interest Burden | 1.04 | 1.00 | 0.98 | 1.54 | 1.19 |
| Research & Development to Revenue | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 |
| SG&A to Revenue | 0.07 | 0.07 | 0.08 | 0.09 | 0.10 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Income Quality | 1.68 | 1.28 | 1.04 | 1.45 | 0.86 |
Currency in TWD
